Elevated baseline serum tryptase, mastocytosis and anaphylaxis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Tryptase is a mediator produced and secreted by mast cells. Both α- and pro-β-tryptase are secreted continuously, mature β-tryptase is stored in mast cell granules and released following mast cell activation, mostly during IgE-mediated allergic reactions, together with histamine, prostaglandins, leukotrienes and other mediators. The commercially available fluorescence immunoassay measures both α- and β-tryptase. The baseline serum level in the absence of an allergic or anaphylactic reaction is considered as an indicator of the whole body mast cell load and, if elevated, may indicate the presence of systemic mastocytosis. If the serum tryptase level increases significantly within 1–5 h after the first symptoms of a suspected systemic hypersensitivity reaction it confirms its mostly allergic, IgE-mediated origin [1]. In this issue, Potier et al. [2] have published an article on cutaneous manifestations during anaphylaxis caused by insect stings and their relation to a baseline serum tryptase (bT) over 13.5 ng/mL. Among 131 patients on venom immunotherapy for anaphylaxis due to Hymenoptera stings they found 14 (10.7%) with an elevated bT. In accordance with previous publications [1, 3, 4] they observed that patients with elevated bT had sustained significantly more severe, mostly cardiovascular anaphylactic sting reactions than those with normal bT. Interestingly they also noted a difference in skin symptoms in these patients compared with those without elevated bT. The latter had urticaria and angioedema more often, while those with elevated bT more often presented with flush as the dominant cutaneous symptom. No systemic cutaneous symptoms were observed in about a quarter of patients with elevated bT, but only in 9% of those with normal bT. Moreover patients with elevated bT had more often suffered repeated anaphylactic sting reactions. Because an elevated bT may be an indicator of systemic mastocytosis the authors also screened for systemic mastocytosis by skin and bone marrow biopsy in 19 of the 23 patients with elevated bT, and diagnosed mastocytosis in seven patients. Because not all patients with elevated bT had biopsies and minor criteria like c-kit mutation and co-expression of CD2/CD25 by kit+mast cells could not be analysed in this study, some cases of systemic mastocytosis may have been missed. We know from two recent large studies on a total of 320 cases of mastocytosis [5, 6] that these patients are at a highly increased risk to develop anaphylaxis, not only to Hymenoptera stings, but also to foods, drugs and other elicitors like alcohol, latex or exercise. Anaphylactic reactions were reported in 22–49% of adult individuals and in 6–9% of children with mastocytosis, while the lifetime prevalence of anaphylaxis in the whole population is estimated to be about 1% [7]. The association of an elevated bT with anaphylaxis has so far only been studied systematically for Hymenoptera stings, but not for other frequent causes of anaphylaxis like foods and drugs. The observation of anaphylaxis due to a Diptera sting in a patient with elevated bT in the study by Potier et al. [2] indicates that bT should be analysed systematically in patients with anaphylaxis, not only those due to frequent causes like venoms, foods or drugs. Several cases of fatal anaphylaxis due to Hymenoptera stings in patients with systemic mastocytosis have been described in the literature [7, 8]. How can we explain the differences in presentation of clinical symptoms between patients with an elevated bT with or without documented mastocytosis, and those with a normal bT: More flush, less urticaria and angioedema: It is well known that mastocytosis patients develop flush and itching to various stimuli besides allergens, like alcohol, exercise, change in temperature, pressure or emotional stress [5, 9, 10], which are obviously not IgE mediated. Besides the increased whole-body load of mastocytes and the consequently higher amount of mediators released, the altered morphology and possibly also production and release of mediators by these cells may attribute to this phenomenon. Mostly severe cardiovascular reactions: During an anaphylactic reaction in patients with an increased whole-body mast cell load very large amounts of mediators can be released, also from mast cells in cardiac tissue and arteries, especially coronary arteries, which are increased in number in patients with systemic mastocytosis, and most likely also in those with elevated bT but not documented mastocytosis [11]. This may be responsible for pharmacologically more threatening levels in the central vascular system including the heart resulting in predominantly cardiovascular symptoms. We observed a tryptase level of over 1000 ng/ml in a post-mortem serum sample from a mastocytosis patient who died from a wasp sting [7]. More frequent recurrent anaphylactic sting reactions in patients with elevated bT: Immunotherapy in patients with mastocytosis and those with an elevate
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Brockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523
Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis
Schwartz, L. B., Bradford, T. R., Rouse, C., Irani, A.-M., Rasp, G., Van Der Zwan, J. K., & Van Der Linden, P.-W. G. (1994) · Journal of Clinical Immunology · doi:10.1007/bf01533368 · Cited by 263
Oude Elberink, J. N. G., de Monchy, J. G. R., Kors, J. W., van Doormaal, J. J., & Dubois, A. E. J. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)81058-5 · Cited by 203
Cited by
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
Simons, F. E. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.981 · Cited by 368
Stinging insect hypersensitivity
Golden, D. B. K., Demain, J., Freeman, T., Graft, D., Tankersley, M., Tracy, J., Blessing-Moore, J., Bernstein, D., Dinakar, C., Greenhawt, M., et al. (2017) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2016.10.031 · Cited by 267
Stinging insect hypersensitivity: A practice parameter update 2011
Golden, D. B. K., Moffitt, J., Nicklas, R. A., Freeman, T., Graft, D. F., Reisman, R. E., Tracy, J. M., Bernstein, D., Blessing-Moore, J., Cox, L., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.025 · Cited by 261
Álvarez-Twose, I., Zanotti, R., González-de-Olano, D., Bonadonna, P., Vega, A., Matito, A., Sánchez-Muñoz, L., Morgado, J. M., Perbellini, O., García-Montero, A., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.06.020 · Cited by 142
Metadata
- Authors
- Müller, U. R.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2009-04-07
- Volume
- 39
- Issue
- 5
- Pages
- 620-622
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2029464419
- Cited by
- 39
- References
- 4
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated baseline serum tryptase, mastocytosis and anaphylaxis. https://app.cochat.ai/papers/10.1111/j.1365-2222.2009.03251.x
- The paper
- Müller, U. R. (2009). Elevated baseline serum tryptase, mastocytosis and anaphylaxis. Clinical & Experimental Allergy. https://doi.org/10.1111/j.1365-2222.2009.03251.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.